Latecomer Janumet XR suffers FDA setback
02 August 2011
Eleanor Malone
Please Login to read the full article.
02 August 2011
Eleanor Malone
eleanor.malone@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- EC approval for BI/Lilly's one-dosage Trajenta for type 2 diabetes
- Three month review delay in US sets Takeda's alogliptin further back in diabetes
- Amylin and Bristol-Myers Squibb deny reports that Amylin rejected $3.5 billion offer
- FDA warns about Actos link to bladder cancer, but no US ban yet
ANALYSIS
Other Informa Analysis
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
